Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis Lauren BrownSamer A. NaffoujeM. Catherine Lee Review 08 October 2022 Pages: 441 - 451
Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma Gustavo A. MorenoMariel I. MolinaJulie M. Jorns Preclinical study 08 October 2022 Pages: 453 - 461
Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center Saba ShafiYan HuZaibo Li Preclinical study 19 October 2022 Pages: 463 - 469
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation H. VihervuoriK. KorpinenP. Kronqvist Preclinical study Open access 19 October 2022 Pages: 471 - 482
PIK3CA-mutations in breast cancer Kristin ReinhardtKathrin StĂĽckrathMartina Vetter Preclinical study Open access 24 October 2022 Pages: 483 - 493
Intrinsic subtypes in Ethiopian breast cancer patient Zelalem DesalegnMeron YohannesMartina Vetter Preclinical study Open access 25 October 2022 Pages: 495 - 504
Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer Olga LobanovaNataliia MedvedievaNatalia Gorovenko Preclinical study 25 October 2022 Pages: 505 - 515
High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy Eumee ChaEmily B. AmbinderKelly S. Myers Clinical trial 15 October 2022 Pages: 517 - 525
The effect of delay of excisional biopsy on upstage rate for atypical ductal hyperplasia, flat epithelial atypia, intraductal papilloma, and radial scar Jesse CasaubonShiva NiakanHolly Mason Clinical trial 01 October 2022 Pages: 527 - 534
Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer Neha VermaAmanda L. BlackfordKaren Lisa Smith Clinical trial 05 October 2022 Pages: 535 - 547
Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) Anne L. LoeserLucy GaoMaryam Lustberg Clinical trial 06 October 2022 Pages: 549 - 563
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age Austin D. WilliamsKate R. PawloskiMahmoud El-Tamer Clinical trial 21 October 2022 Pages: 565 - 570
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane Paula R. PohlmannDeena GrahamSandra M. Swain Clinical trial Open access 25 October 2022 Pages: 571 - 581
Patterns of breast cancer second recurrences in patients after mastectomy Geok Hoon LimVeronica Siton AlcantaraQing Ting Tan Clinical trial 26 October 2022 Pages: 583 - 589
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors Annemiek van Ommen-NijhofJudy N. JacobseGabe S. Sonke Epidemiology 01 October 2022 Pages: 591 - 602
Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis Jeanna Wallenta LawAlicyn CampbellHenry G. Kaplan Epidemiology Open access 06 October 2022 Pages: 603 - 611
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study Qiufan ZhengHanjia LuoShusen Wang Epidemiology 07 October 2022 Pages: 613 - 622
Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors Rachel A. FreedmanNaomi Y. KoNancy L. Keating Epidemiology 11 October 2022 Pages: 623 - 633
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma Tomohiko AiharaHiraku KumamaruHiromitsu Jinno Epidemiology 23 October 2022 Pages: 635 - 645
A population health assessment of screening mammography on breast cancer mortality in North Carolina Ashley E. BurchWilliam D. IrishJan H. Wong Epidemiology 26 October 2022 Pages: 647 - 656
Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction Hope M. GuzzoStephanie A. ValenteZahraa Al-Hilli Original Laboratory Investigation 14 October 2022 Pages: 657 - 664
Retraction Note to: Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression Zhongxing LiangXuehai BianHyunsuk Shim Retraction Note 23 October 2022 Pages: 665 - 665